← FDA Drug Approvals (Drugs@FDA)

SEEBRI NEOHALER

NDA · New Drug Application · Sponsor: NOVARTIS · Approved 2015-10-29

Drug application

FDA Application #

NDA207923

Application type

New Drug Application

Brand name

SEEBRI NEOHALER

Generic name

Glycopyrrolate

Active ingredients

GLYCOPYRROLATE

Dosage form

POWDER

Route

INHALATION

Marketing status

Discontinued

Sponsor

NOVARTIS

First approval

2015-10-29

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown